Scripps Health, Prebys Cancer Center

San Diego, California 92103

1 studies enrolling now · 2 studies all time

What they study most

B-Cell Non-Hodgkin Lymphoma, MF, Myelofibrosis, Post-ET Myelofibrosis, Post-PV MF, Primary Myelofibrosis, Refractory B-Cell Non-Hodgkin Lymphoma, Relapsed B-Cell Non-Hodgkin Lymphoma

Studies at this site

• Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib — Recruiting now
• A Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer Agents in Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7) — Running, not enrolling